two weeks on semaglutide and no weight loss It has been nearly since the #semaglutide patent expired, India's weight-loss drug market is already opening up to cheaper generics. For a country grappling with a rising #obesity burden—driven My thoughts after 12 months

Experiences shared by clients are personal and may not reflect typical outcomes

Current treatments primarily aim to modulate platelet signaling to prevent thrombosis in cardiovascular diseases or to reduce excessive platelet aggregation in other pathological conditions

5 The benefit was seen across baseline blood sugar levels, including in those who started with HbA1c in the prediabetes range

Oral tirzepatide is in development and early availability, offering a needle-free option

It is a vital compound found in every cell of our body, primarily produced in the liver

A phase 3 trial of a higher-dose CagriSema formulation at 2.4/7.2 mg is planned for initiation in the second half of 2026, and the REDEFINE 11 trial, exploring CagriSemas full weight-loss potential, is expected to report data in the first half of 2027